| Date | Title | Description |
| 16.09.2026 | ReEmerge Launches With $37M Series A |
EDINA, MN, ReEmerge, a private MedTech company innovating a new way to address cognitive impairment, has launched from stealth following the close of an oversubscribed $37 million Series A financing.
>> Click here for more funding da... |
| 07.04.2026 | Endovascular Engineering Raises $80M Series C Funding | Endovascular Engineering, Inc., a Menlo Park, CA-based commercial-stage medical technology company, raised $80M in Series C funding.
The round was led by Gilde Healthcare and Norwest, with participation from existing investors including San... |
| 24.01.2026 | TRiCares: Up To €20 Million EIB Loan Secured To Advance Topaz Tricuspid Valve Replacement Trials | TRiCares SAS, a privately held medtech company developing a minimally invasive treatment for tricuspid regurgitation, said it has signed a loan agreement for up to €20 million in non-dilutive financing with the European Investment Bank, the... |
| 28.03.2025 | Supira Medical: $120 Million (Series E) Raised For Transforming The Percutaneous Ventricular Assist Device Market | Supira Medical – a clinical-stage Shifamed portfolio company – announced the completion of an oversubscribed Series E financing round, raising $120 million to accelerate the company’s mission of transforming the percutaneous ventricular ass... |
| 12.09.2024 | CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment | CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round |
Headquarted in Baar (Zug), CorFlow’s Controlled Flow Infusion (CoFI) system is being developed to provide timely, accurate and consistent detection of Microvascular Obstruction (MVO) while patients are still in the catheter laboratory (cat... |
| 12.09.2024 | CorFlow Therapeutics: €44 Million (Series B) Raised For Advancing Drug Delivery Platform Related To Microvascular Obstruction In Heart Attack Patients | CorFlow Therapeutics AG announced that it has raised €44 million in Series B funding, co-led by Broadview Ventures and Panakes Partners with strong continued support from 415 Capital (CorFlow’s initial VC investor and largest shareholder). ... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round |
Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington... |
| 27.07.2024 | TRiCares: Medical Device Company Raises $50 Million In Series D | TRiCares SAS, a privately held pioneer in the minimally invasive treatment of tricuspid regurgitation, announced it has raised $50 million (€46 million) in a Series D funding round. The funding round was raised from a single strategic inves... |
| 09.03.2024 | Aktiia Revolutionizes Blood Pressure Monitoring | Aktiia, a Swiss HealthTech company, secures USD 30M in funding to advance its mission of easing the global burden of hypertension through AI-driven technology. Led by Redalpine, the funding round includes investors like Khosla Ventures and ... |
| 04.03.2024 | Aktiia: Wrist-Worn 24/7 Optical Blood Pressure Monitoring Company Raises CHF 27 Million | Aktiia – the Swiss HealthTech innovator that developed the world’s first wrist-worn 24/7 optical blood pressure monitoring device – announced the completion of a CHF 27 million (USD 30M) funding round, led by Redalpine with participation fr... |
| 27.02.2024 | Aktiia banks CHF 27 million to mitigate hypertension worldwide |
Over 1.4 billion people worldwide are affected by high blood pressure, resulting in more than 18 million related deaths annually. This strategic infusion of capital will accelerate Aktiia's mission to ease the global burden of hypertension... |
| 26.01.2022 | Distalmotion raises $90M to accelerate adoption of surgical robot Dexter | |
| 02.11.2021 | Aktiia closes $17.5 million Series A financing round | |
| 04.10.2021 | Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde Euro | Startup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google.
... |
| 20.07.2021 | MedTech VC Firm 415 CAPITAL Announces Strategic Alliance With European Healthcare Service Provider Uniphar Group PLC | Partnership formed on the back of Uniphar Group PLC’s acquisition of CoRRect Medical GmbH, a leading Germany-based distributor of innovative medical device technologies, co-founded by 415 CAPITAL’s partners
OBERHACHING, Germany–(BUSINESS WI... |
| 20.07.2021 | MedTech VC Firm 415 CAPITAL Announces Strategic Alliance With European Healthcare Service Provider Uniphar Group PLC | All the sessions from Transform 2021 are available on-demand now. Watch now.
Partnership formed on the back of Uniphar Group PLC’s acquisition of CoRRect Medical GmbH, a leading Germany-based distributor of innovative medical device technol... |
| 24.06.2021 | Cardiac Success Secures $5.2M for Transcatheter Ventricular Repair Device for Heart Failure Patients | What You Should Know:
– Cardiac Success Ltd., an Israel-based medical device company developing a transcatheter ventricular repair device for heart failure patients, announced it has raised $5.2M in Series A funding round led by 415 CAPITAL... |
| 23.06.2021 | Israeli Medical Device Startup, Cardiac Success Ltd., Closes US $5.2M Series A Financing | Boaz Manash, CEO at Cardiac Success The “V-sling” system aims to provide a new treatment approach by transforming an invasive open-heart surgery into a safe and effective minimally-invasive transcatheter procedure.
YOKNEAM, Israel (PRWEB) J... |
| 12.04.2021 | Berlin-based Heal Capital invests in medtech Moray Medical | Mountain View, CA-based robotic surgery firm Moray Medical has closed a seed funding round totaling $5.7 million.
Led by 415 Capital, the round saw participation from Berlin-based Heal Capital and a number of angel investors including the A... |
| 27.01.2021 | Interventional Robotics Startup Moray Medical Secures $3.3 Million Seed Financing Led by 415 CAPITAL | Moray Medical announced today that it has raised $3.3 million in seed funding led by 415 CAPITAL, which invested alongside a number of prominent medtech entrepreneurs.
Moray is developing the CoralTMsystem, a novel interventional robotics p... |
| 27.01.2021 | Interventional Robotics Startup Moray Medical Secures $3.3 Million Seed Financing Led by 415 CAPITAL | Company also elects new board member
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–January 27, 2021–
Moray Medical announced today that it has raised $3.3 million in seed funding led by 415 CAPITAL, which invested alongside a number of prominent me... |
| 09.10.2020 | StartUPDATES: New developments for healthcare startups | ChromaCode’s HDPCR™ SARS-CoV-2 assay has moved on to the Semi-Finals Round of the XPRIZE Rapid Covid Testing Competition, aiming to increase Covid-19 testing capabilities 100-times past our current standard.
R3 Vascular, a medical device co... |
| - | Berlin-based Heal Capital invests in medtech Moray Medical | Mountain View, CA-based robotic surgery firm Moray Medical has closed a seed funding round totaling $5.7 million.
Led by 415 Capital, the round saw participation from Berlin-based Heal Capital and a number of angel investors including the A... |
| - | This Week in European Tech: Major rounds for Fever, Zapp and Paack; Gorillas and Glovo buy smaller peers; good news for Intel, bad news for Sigfox | Happy Friday!
This week, the Tech.eu research team tracked more than 135 tech funding deals worth over €2.9 billion, and over 25 exits, M&A transactions, and rumours, and related news stories across Europe, including Russia and Turkey.
... |
| - | Meet Dexter, the robot that will make surgery more efficient as Lausanne startup plans global roll out with $90 million | Switzerland-based medical device company Distalmotion has raised $90 million in its Series E funding to boost its commercial scaling. The round was led by Austin-based Revival Healthcare Capital with participation from 415 CAPITAL, as well ... |
| - | StartUPDATES: New developments for healthcare startups | ChromaCode’s HDPCR™ SARS-CoV-2 assay has moved on to the Semi-Finals Round of the XPRIZE Rapid Covid Testing Competition, aiming to increase Covid-19 testing capabilities 100-times past our current standard.
R3 Vascular, a medical device co... |
